Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries

DOI Web Site Web Site PubMed 被引用文献3件 参考文献214件
  • HORISAWA Kenichi
    Division of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University
  • SUZUKI Atsushi
    Division of Organogenesis and Regeneration, Medical Institute of Bioregulation, Kyushu University

この論文をさがす

抄録

<p>Cells of multicellular organisms have diverse characteristics despite having the same genetic identity. The distinctive phenotype of each cell is determined by molecular mechanisms such as epigenetic changes that occur throughout the lifetime of an individual. Recently, technologies that enable modification of the fate of somatic cells have been developed, and the number of studies using these technologies has increased drastically in the last decade. Various cell types, including neuronal cells, cardiomyocytes, and hepatocytes, have been generated using these technologies. Although most direct reprogramming methods employ forced transduction of a defined sets of transcription factors to reprogram cells in a manner similar to induced pluripotent cell technology, many other strategies, such as methods utilizing chemical compounds and microRNAs to change the fate of somatic cells, have also been developed. In this review, we summarize transcription factor-based reprogramming and various other reprogramming methods. Additionally, we describe the various industrial applications of direct reprogramming technologies.</p>

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (214)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ